{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:54:03Z","timestamp":1785801243772,"version":"3.56.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21173"],"award-info":[{"award-number":["21173"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21754"],"award-info":[{"award-number":["21754"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21755"],"award-info":[{"award-number":["21755"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.berh.2023.101857","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:26:07Z","timestamp":1691011567000},"page":"101857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The association between comorbidities and disease activity in spondyloarthritis \u2013 A narrative review"],"prefix":"10.1016","volume":"37","author":[{"given":"Philipp","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","article-title":"Concepts and epidemiology of spondyloarthritis","volume":"20","author":"Sieper","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"issue":"Suppl4","key":"10.1016\/j.berh.2023.101857_bib3","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","article-title":"Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/annrheumdis-2016-209233","article-title":"Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative","volume":"75","author":"Baillet","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre-therapeutic classification OF CO-morbidity in chronic disease","volume":"23","author":"Feinstein","year":"1970","journal-title":"J\u00a0Chron Dis"},{"issue":"10","key":"10.1016\/j.berh.2023.101857_bib6","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1093\/rheumatology\/keac134","article-title":"Comorbidities or extra-articular manifestations: time to reconsider the terminology?","volume":"61","author":"Dey","year":"2022","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3899\/jrheum.150648","article-title":"Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome","volume":"43","author":"Maas","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.semarthrit.2021.07.021","article-title":"The ASAS-OMERACT core domain set for axial spondyloarthritis","volume":"51","author":"Navarro-Comp\u00e1n","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2023.101857_bib12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/reum.2020.93506","article-title":"The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis - a cross-sectional study","volume":"58","author":"Sharma","year":"2020","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pain.2005.05.016","article-title":"Pain perception in major depression depends on pain modality","volume":"117","author":"B\u00e4r","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.berh.2023.101857_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fmed.2018.00062","article-title":"Comorbidities in spondyloarthritis","volume":"5","author":"Molt\u00f3","year":"2018","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib18","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/rheumatology\/kez237","article-title":"Evaluating current definitions of low disease activity in psoriatic arthritis using ultrasound","volume":"58","author":"Bosch","year":"2019","journal-title":"Rheumatology"},{"issue":"SI","key":"10.1016\/j.berh.2023.101857_bib19","doi-asserted-by":"crossref","first-page":"SI92","DOI":"10.1093\/rheumatology\/keab764","article-title":"The role of tender and swollen joints for the assessment of inflammation in PsA using ultrasound","volume":"61","author":"Bosch","year":"2022","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib20","first-page":"122","article-title":"Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. Administrative claims data","volume":"25","author":"Kaine","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatology"},{"issue":"9587","key":"10.1016\/j.berh.2023.101857_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2003.00514.x","article-title":"The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs","volume":"5","author":"Morgan","year":"2003","journal-title":"J\u00a0Clin Hypertens"},{"issue":"11","key":"10.1016\/j.berh.2023.101857_bib25","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/acr.24070","article-title":"Nonsteroidal antiinflammatory drug use and association with incident hypertension in ankylosing spondylitis","volume":"72","author":"Liew","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-020-02301-0","article-title":"The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study","volume":"22","author":"Redeker","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.berh.2023.101857_bib27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/annrheumdis-2016-210579","article-title":"Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study","volume":"76","author":"Kristensen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib28","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1093\/rheumatology\/keac210","article-title":"All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study","volume":"61","author":"Kerola","year":"2022","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.16919","article-title":"Cause-specific mortality in patients with psoriasis and psoriatic arthritis","volume":"180","author":"Skov","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"issue":"6116","key":"10.1016\/j.berh.2023.101857_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib34","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2023.101857_bib36","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2012-203137","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","volume":"73","author":"Lindhardsen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"10.1016\/j.berh.2023.101857_bib37","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"10.1016\/j.berh.2023.101857_bib39","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Score working group","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2023.101857_bib40","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"29","key":"10.1016\/j.berh.2023.101857_bib41","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2023.101857_bib42","article-title":"EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","author":"Fragoulis","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3899\/jrheum.140067","article-title":"The incidence and predictors of infection in psoriasis and psoriatic arthritis: results from longitudinal observational cohorts","volume":"43","author":"Haddad","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2023.101857_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1040725","article-title":"Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis","volume":"13","author":"Frede","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib45","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.4049\/jimmunol.172.7.4435","article-title":"Preferential HLA usage in the influenza virus-specific CTL response","volume":"172","author":"Boon","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.berh.2023.101857_bib46","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.4049\/jimmunol.162.11.6942","article-title":"New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS","volume":"162","author":"Hendel","year":"1999","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","article-title":"Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection","volume":"64","author":"Fitzmaurice","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"Update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101857_bib50","series-title":"Eurostat - body mass index (BMI) by sex, age and educational attainment level","year":"2022"},{"key":"10.1016\/j.berh.2023.101857_bib51","series-title":"Obesity and overweight","year":"2020"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020485","article-title":"Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management","volume":"15","author":"Pati","year":"2023","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.berh.2023.101857_bib53","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib54","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch Gen Psychiatr"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","article-title":"Obesity and psoriatic arthritis: a narrative review","volume":"7","author":"Kumthekar","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"8","key":"10.1016\/j.berh.2023.101857_bib56","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib57","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.ijo.0800770","article-title":"Adipose tissue as an endocrine and paracrine organ","volume":"22","author":"Mohamed-Ali","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"10","key":"10.1016\/j.berh.2023.101857_bib58","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/092986707780362826","article-title":"The contribution of adipose tissue and adipokines to inflammation in joint diseases","volume":"14","author":"Toussirot","year":"2007","journal-title":"Curr Med Chem"},{"issue":"8","key":"10.1016\/j.berh.2023.101857_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11926-020-00917-4","article-title":"Obesity increases disease activity of Norwegian patients with axial spondyloarthritis: results from the European map of axial spondyloarthritis survey","volume":"22","author":"Bindesb\u00f8ll","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001225","article-title":"Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis","volume":"6","author":"Liew","year":"2020","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib61","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/acr.24416","article-title":"Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis","volume":"73","author":"Ortolan","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.berh.2023.101857_bib62","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3899\/jrheum.190219","article-title":"Measuring outcomes in psoriatic arthritis: comparing routine assessment of patient index data and psoriatic arthritis impact of disease","volume":"47","author":"Walsh","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acr.21711","article-title":"Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis","volume":"65","author":"di Minno","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.berh.2023.101857_bib65","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/annrheumdis-2018-213585","article-title":"EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis","volume":"77","author":"Rausch Osthoff","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101857_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20970028","article-title":"Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management","volume":"12","author":"Parkinson","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.berh.2023.101857_bib67","unstructured":"Institute of Health Metrics and Evaluation. Global health data exchange (GHDx) [Available from: https:\/\/vizhub.healthdata.org\/gbd-results\/, Access date: 4.March.2023."},{"issue":"10","key":"10.1016\/j.berh.2023.101857_bib68","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/rheumatology\/kez119","article-title":"Comorbidity burden in axial spondyloarthritis: a cluster analysis","volume":"58","author":"Zhao","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-019-04734-8","article-title":"Systematic review of mental health comorbidities in psoriatic arthritis","volume":"39","author":"Zhao","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101857_bib70","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib72","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1093\/rheumatology\/keab242","article-title":"Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis","volume":"60","author":"Zhao","year":"2021","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/annrheumdis-2019-216034","article-title":"Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis","volume":"79","author":"Kiltz","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101857_bib74","series-title":"Depression in adults with a chronic physical health problem: recognition and management. London","year":"2009"},{"key":"10.1016\/j.berh.2023.101857_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies","volume":"118","author":"Laporte","year":"2017","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib76","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/rheumatology\/keac580","article-title":"The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?","volume":"62","author":"Webers","year":"2023","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.berh.2023.101857_bib77","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/annrheumdis-2021-220249","article-title":"EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis","volume":"80","author":"Nikiphorou","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib78","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","article-title":"The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari","year":"2021","journal-title":"J\u00a0Orthop Surg Res"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.qai.0000435598.20104.d6","article-title":"Peak bone mass in young HIV-infected patients compared with healthy controls","volume":"65","author":"Negredo","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.berh.2023.101857_bib80","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/acr.24538","article-title":"Prevalence and factors associated with osteoporosis and bone mineral density testing in psoriatic arthritis","volume":"74","author":"Kwok","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semarthrit.2017.12.001","article-title":"Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: a systematic review and meta-analysis","volume":"48","author":"Ram\u00edrez","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib82","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bone.2008.12.028","article-title":"Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis","volume":"44","author":"Ghozlani","year":"2009","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib83","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.berh.2023.101857_bib84","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2012-201845","article-title":"Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort","volume":"72","author":"Briot","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101857_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.569449","article-title":"A\u00a0contemporary view of the diagnosis of osteoporosis in patients with axial spondyloarthritis","volume":"7","author":"Lim","year":"2020","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib86","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00223-017-0356-2","article-title":"Bone disease in axial spondyloarthritis","volume":"102","author":"Van Mechelen","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib87","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s001980170084","article-title":"Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study","volume":"12","author":"Maillefert","year":"2001","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.berh.2023.101857_bib88","first-page":"465","article-title":"Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases","volume":"33","author":"Wang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib89","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3349\/ymj.2003.44.3.379","article-title":"Bone mineral density in mild and advanced ankylosing spondylitis","volume":"44","author":"Capaci","year":"2003","journal-title":"Yonsei Med J"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib90","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00296-012-2632-9","article-title":"Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis","volume":"33","author":"Ulu","year":"2013","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib91","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14397595.2018.1510877","article-title":"Inflammation on spinal magnetic resonance imaging is associated with poor bone quality in patients with ankylosing spondylitis","volume":"29","author":"Jung","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib92","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/rheumatology\/kev332","article-title":"Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort","volume":"55","author":"Briot","year":"2016","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib93","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/qjmed\/hcu027","article-title":"Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study","volume":"107","author":"Shen","year":"2014","journal-title":"QJM"},{"issue":"2\u20133","key":"10.1016\/j.berh.2023.101857_bib94","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12026-013-8395-x","article-title":"Autoimmune smoke and fire--coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis","volume":"56","author":"Bieber","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.berh.2023.101857_bib95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2018.04.002","article-title":"The link between COPD and ankylosing spondylitis: a population based study","volume":"53","author":"Sharif","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib96","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1183\/09031936.00070410","article-title":"Subsequent COPD and lung cancer in patients with autoimmune disease","volume":"37","author":"Hemminki","year":"2011","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116608","article-title":"The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study","volume":"10","author":"Shen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2023.101857_bib98","article-title":"Concomitant interstitial lung disease with psoriasis","volume":"2019","author":"Ishikawa","year":"2019","journal-title":"Cancer Res J"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib99","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/ard-2022-223297","article-title":"Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis","volume":"82","author":"Ortolan","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1222441","article-title":"Restrictive chest wall disorders","volume":"30","author":"Donath","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib101","article-title":"Physiotherapy interventions for ankylosing spondylitis","volume":"2008","author":"Dagfinrud","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/srep32063","article-title":"Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis","volume":"6","author":"Deng","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bjc.1987.35","article-title":"Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis","volume":"55","author":"Darby","year":"1987","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.berh.2023.101857_bib104","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.rdc.2020.04.001","article-title":"Risk of malignancy in spondyloarthritis: a systematic review","volume":"46","author":"Karmacharya","year":"2020","journal-title":"Rheum Dis Clin N Am"},{"issue":"7","key":"10.1016\/j.berh.2023.101857_bib105","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib106","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2017.6368","article-title":"Ankylosing spondylitis and the risk of cancer","volume":"14","author":"Chang","year":"2017","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.berh.2023.101857_bib107","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","article-title":"Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib108","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2010.08.005","article-title":"Cancer in patients with rheumatic diseases exposed to TNF antagonists","volume":"41","author":"Carmona","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2023.101857_bib109","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.38339","article-title":"Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden","volume":"66","author":"Hellgren","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2023.101857_bib110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semarthrit.2018.05.009","article-title":"Malignancy development risk in psoriatic arthritis patients undergoing treatment: a systematic review and meta-analysis","volume":"48","author":"Luo","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2230.1991.tb00314.x","article-title":"Psoriasis therapy and the risk of skin cancers","volume":"16","author":"Mali-Gerrits","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.berh.2023.101857_bib112","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20925696","article-title":"Risk of malignancies in patients with spondyloarthritis treated with biologics compared with those treated with non-biologics: a systematic review and meta-analysis","volume":"12","author":"Kwan","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2012-201969","article-title":"Incidences of overall and site specific cancers in TNF\u03b1 inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry","volume":"72","author":"Dreyer","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib114","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/key241","article-title":"Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register","volume":"58","author":"Fagerli","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2023.101857_bib115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/art.37740","article-title":"Tumor necrosis factor \u03b1 inhibitor therapy and cancer risk in chronic immune-mediated diseases","volume":"65","author":"Haynes","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2023.101857_bib116","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/fcp.12171","article-title":"Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database","volume":"30","author":"Saliba","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.berh.2023.101857_bib117","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/acr.23468","article-title":"Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: results from the assessment of SpondyloArthritis international society comorbidities in spondyloarthritis study","volume":"70","author":"Nikiphorou","year":"2018","journal-title":"Arthritis Care Res"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:23:32Z","timestamp":1761499412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694223000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1521694223000438"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101857","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between comorbidities and disease activity in spondyloarthritis \u2013 A narrative review","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101857"}}